Ampharm Revenue and Competitors
Estimated Revenue & Valuation
- Ampharm's estimated annual revenue is currently $14.3M per year.
- Ampharm's estimated revenue per employee is $201,000
Employee Data
- Ampharm has 71 Employees.
- Ampharm grew their employee count by 27% last year.
Ampharm's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Pharmacy Operations | Reveal Email/Phone |
2 | Director Business Development | Reveal Email/Phone |
3 | Director Financial Operations | Reveal Email/Phone |
4 | Director Pharmacy Operations | Reveal Email/Phone |
5 | Pharmacy Systems Project Manager | Reveal Email/Phone |
6 | Pharmacy Manager | Reveal Email/Phone |
7 | Care Coordinator | Reveal Email/Phone |
8 | Pharmacist LTC | Reveal Email/Phone |
9 | Credentialing Specialist | Reveal Email/Phone |
10 | Certified Pharmacy Technician | Reveal Email/Phone |
Ampharm Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.2M | 6 | 20% | N/A | N/A |
#2 | $152.8M | 543 | 0% | $28.5M | N/A |
#3 | $102.7M | 511 | 0% | N/A | N/A |
#4 | $62.1M | 309 | 6% | N/A | N/A |
#5 | $10.1M | 50 | -2% | N/A | N/A |
#6 | $31.2M | 155 | -4% | N/A | N/A |
#7 | $23.7M | 118 | 12% | $23.6M | N/A |
#8 | $5.8M | 29 | 4% | N/A | N/A |
#9 | $14.3M | 71 | 27% | N/A | N/A |
#10 | $15.9M | 79 | 7% | N/A | N/A |
What Is Ampharm?
Where Savings and Peace of Mind Converge. AmPharm is long-term-care pharmacy providing custom-packaged medications to nursing homes, assisted living communities and psychiatric hospitals. We work closely with our partners to improve dosing compliance, reduce errors and manage costs.
keywords:N/AN/A
Total Funding
71
Number of Employees
$14.3M
Revenue (est)
27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.7M | 71 | 39% | N/A |
#2 | $16.2M | 71 | 34% | N/A |
#3 | $17.8M | 71 | 20% | N/A |
#4 | $10.2M | 71 | 25% | N/A |
#5 | $10.4M | 72 | 132% | N/A |
